Iovance Biotherapeutics Inc (IOVA)

[Sunman88]

With about $365m left and burn rate of over $110m per qtr, Share price action suggests some big sellers are focused on the burn rate and the possible need to dilute by late 2024 or early 2025. Also, they may have been expecting demand projections to be in several hundreds and may have misunderstood the context of “100 patients are being screened and some are not making the cut”. TIL is a process with a lot of logistics involved and cost is high. Ramp up will be gradual pace and not rapid. Some are using this to create FUD and shock the longs. It boils down to having faith in the technology and execution over time versus killing the hen that lays one golden egg daily in hopes of getting several hundred today.